PEDIAPHARM NAPROXEN SUSPENSION
Google image searchProduct monograph
Active ingredient
naproxen, 25 MG/ML
DIN: 02162431
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: MEDEXUS PHARMACEUTICALS INC.
Date: 20-DEC-2022
ATC:
- M01 — ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS (ATC, ATC/DDD, )
- M01A — ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS (ATC, ATC/DDD)
- M01AE — Propionic acid derivatives (ATC, ATC/DDD)
- M01AE02 — NAPROXEN (ATC/DDD)
Reference brand drug: Aleve, Anaprox, Naprelan, Naprosyn
Pharmaceutical standard: USP
